121
Participants
Start Date
November 9, 2020
Primary Completion Date
April 18, 2024
Study Completion Date
December 23, 2024
Elezanumab
Intravenous (IV) infusion
Placebo
Intravenous (IV) infusion
Royal North Shore Hospital /ID# 239083, St Leonards
The Royal Melbourne Hospital /ID# 240178, Parkville
Duplicate_CHA University Bundang Medical Center /ID# 233503, Seongnam-si
Complejo Hospitalario Universitario A Coruña /ID# 230080, A Coruña
Lehigh Valley Health Network /ID# 242446, Allentown
Thomas Jefferson University Hospital /ID# 215469, Philadelphia
Georgetown University Hospital /ID# 216481, Washington D.C.
Hospital Donostia /ID# 218034, Donostia / San Sebastian
University of Virginia /ID# 215757, Charlottesville
Hospital Universitario La Paz /ID# 216380, Madrid
Mayo Clinic /ID# 217567, Jacksonville
University of Louisville Hospital /ID# 217569, Louisville
Duplicate_University of Kentucky Chandler Medical Center /ID# 216394, Lexington
Hospital Universitario Virgen Macarena /ID# 216382, Seville
Hospital Universitario Virgen del Rocio /ID# 216339, Seville
The Ohio State University /ID# 215036, Columbus
UH Cleveland Medical Center /ID# 215372, Cleveland
Cleveland Clinic Main Campus /ID# 214635, Cleveland
OSI Ezkerraldea-Enkarterri-Cruces /ID# 217529, Barakaldo
Duplicate_Pusan National University Hospital /ID# 233769, Busan
Washington University-School of Medicine /ID# 214526, St Louis
Mayo Clinic Arizona /ID# 214957, Phoenix
Nagano Municipal Hospital /ID# 240622, Nagano
Long Beach Medical Center /ID# 217210, Long Beach
Northwestern University Feinberg School of Medicine /ID# 215047, Chicago
Tufts Medical Center /ID# 215053, Boston
University of Mississippi Medical Center /ID# 217587, Jackson
St. Luke's Marion Bloch Neuroscience Institute /ID# 215028, Kansas City
Hackensack Univ Med Ctr /ID# 218200, Hackensack
University of New Mexico School of Medicine /ID# 216827, Albuquerque
Columbia University Medical Center /ID# 215122, New York
University of Texas Health Science Center at Houston /ID# 215018, Houston
Baylor Scott & White Medical Center- Temple /ID# 225513, Temple
University of Alberta Hospital /ID# 218370, Edmonton
Hamilton General Hospital /ID# 218970, Hamilton
Fukuoka University Chikushi Hospital /ID# 240629, Chikushino-shi
Fukuoka Wajiro Hospital /ID# 239810, Fukuoka
National Hospital Organization Kagoshima Medical Center /ID# 240021, Kagoshima
Yamaguchi Grand Medical Center /ID# 239892, Hohu-shi
Seoul National University Hospital /ID# 233473, Seoul
Samsung Medical Center /ID# 234241, Seoul
Hospital Universitario Vall d'Hebron /ID# 217087, Barcelona
Lead Sponsor
AbbVie
INDUSTRY